Literature DB >> 10852121

T cell receptor binding kinetics and special role of Valpha in T cell development and activation.

N R Gascoigne1, S M Alam, C M Lin, M V McGuire, S Marine, N Niederberger, S Redpath, B C Sim, P J Travers, P Yachi, M A Zal, T Zal.   

Abstract

The kinetics of the interaction between T cell receptor (TCR) and major histocompatibility complex (MHC) has an important role in determining thymocyte-positive and -negative selection in the thymus, as well as in T cell activation. The alpha chain of the TCR is the major player in determining how the TCR fits onto the MHC ligand, and thus has a major role in determining whether a T cell develops as class I or class II restricted. In this article, we summarize recent data from our laboratory and others on the role of polymorphism in the Valpha combining site in determining MHC class restriction, and on kinetic parameters in thymocyte selection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852121     DOI: 10.1385/IR:21:2-3:225

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  27 in total

1.  Reciprocal expression in CD4 or CD8 subsets of different members of the V alpha 11 gene family correlates with sequence polymorphism.

Authors:  B C Sim; N R Gascoigne
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

2.  TCR binding to peptide-MHC stabilizes a flexible recognition interface.

Authors:  B E Willcox; G F Gao; J R Wyer; J E Ladbury; J I Bell; B K Jakobsen; P A van der Merwe
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

3.  A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists.

Authors:  D S Lyons; S A Lieberman; J Hampl; J J Boniface; Y Chien; L J Berg; M M Davis
Journal:  Immunity       Date:  1996-07       Impact factor: 31.745

4.  Polymorphism within a TCRAV family influences the repertoire through class I/II restriction.

Authors:  B C Sim; J L Wung; N R Gascoigne
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

5.  Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen.

Authors:  K C Garcia; M Degano; L R Pease; M Huang; P A Peterson; L Teyton; I A Wilson
Journal:  Science       Date:  1998-02-20       Impact factor: 47.728

6.  Ligand-specific oligomerization of T-cell receptor molecules.

Authors:  Z Reich; J J Boniface; D S Lyons; N Borochov; E J Wachtel; M M Davis
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

Review 7.  Positive selection of thymocytes.

Authors:  S C Jameson; K A Hogquist; M J Bevan
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

8.  MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent.

Authors:  E O Matechak; N Killeen; S M Hedrick; B J Fowlkes
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

9.  Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness.

Authors:  K Matsui; J J Boniface; P Steffner; P A Reay; M M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  Amino acids specifying MHC class preference in TCR V alpha 2 regions.

Authors:  M Correia-Neves; C Waltzinger; J M Wurtz; C Benoist; D Mathis
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

View more
  2 in total

1.  The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition.

Authors:  Stéphane Sidobre; Kirsten J L Hammond; Lise Bénazet-Sidobre; Sergei D Maltsev; Stewart K Richardson; Rachel M Ndonye; Amy R Howell; Teruyuki Sakai; Gurdyal S Besra; Steven A Porcelli; Mitchell Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-10       Impact factor: 11.205

Review 2.  T cell sensitivity and the outcome of viral infection.

Authors:  L J Walker; A K Sewell; P Klenerman
Journal:  Clin Exp Immunol       Date:  2009-12-01       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.